Latest news
Loading news…
Galantos Pharma
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Mainz, Rheinland-Pfalz, Germany Founded 2005 1-10 employees For Profit
Galantos Pharma is a drug development company focusing on new drugs for neurodegenerative diseases such as Alzheimer’s Dementia.
Galantos Pharma was acquired by Alpha Cognition in 2013.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 6
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2005
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- Mainz, Rheinland-Pfalz, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Sep 4, 2013
- Closed
- Sep 4, 2013
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 0
- Trend (90d)
- 2.6
Key People at Galantos Pharma
Founder & CEO
Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Galantos Pharma
Loading news…
FAQs about Galantos Pharma
People who checked this page also checked these
Browse the full Acquirezy directory.